RPTOR and intervertebral disk degenerative disorder: More specifically, based on by the consistent anti‐apoptotic, anti‐senescent, and anti‐catabolic effects of mTORC1/RAPTOR RNAi and mTORC1‐inhibiting temsirolimus administration, the application to prevent the chronic progression of disc degeneration, for example, by gene therapy, and also to treat the acute phase of painful discs, for example, by pharmaceuticals, would be suggested after careful animal testing and human clinical trials.